Know Cancer

or
forgot password

Estimating the Adherence Rate of a Monthly Bubble Package Among Women Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors


N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Estimating the Adherence Rate of a Monthly Bubble Package Among Women Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors


This study uses Bubble packaging to provide a cost effective way to improve compliance and
help direct further interventions to ensure adherence in women on anti-estrogen therapy for
breast cancer.


Inclusion Criteria:



- 18 years of age or older

- Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry

- Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine
therapy

Exclusion Criteria:

- Patients with metastatic disease (stage IV)

- Patients less than 18 years of age

- Prisoners

- Patients are unable to fill prescriptions at the BCC pharmacy due to insurance
limitations or personal preference

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Elizabeth C Riley, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

James Graham Brown Cancer Center- U of Louisville

Authority:

United States: Institutional Review Board

Study ID:

BCC-BRE-12-Adherence

NCT ID:

NCT01694225

Start Date:

July 2012

Completion Date:

July 2015

Related Keywords:

  • Breast Cancer
  • Breast cancer
  • Anti-estrogen therapy
  • Breast Neoplasms

Name

Location

James Graham Brown Cancer Center-University of LouisvilleLouisville, Kentucky  40202